Mathai Mammen

Mathai Mammen

Directeur/Membre du Conseil chez SANDOZ GROUP AG

Fortune : 3 M $ au 31/10/2024

57 ans
Health Technology
Finance
Consumer Services

Profil

Mathai Mammen is the founder of Innoviva, Inc. (founded in 1996) and Theravance Biopharma, Inc. (founded in 1997).
He held the title of Senior VP-Research & Early Clinical Development at Innoviva, Inc. from 2011 to 2014 and the title of Senior Vice President-Research & Development at Theravance Biopharma, Inc. from 2014 to 2016.
Dr. Mammen's current job(s) include Chairman, President & Chief Executive Officer at Fog Pharmaceuticals, Inc., Director at MIT Jameel Clinic, Independent Director at Sandoz Group AG (starting in 2024), Advisor at Foresite Capital Management LLC, and Senior Advisor at General Atlantic LLC.
Dr. Mammen's former job(s) include Independent Director at 10X Genomics, Inc. (2017-2024), Senior Vice President at Merck Research Laboratories Massachusetts LLC (2016-2017), Global Head-Research & Development at Janssen Research & Development LLC (2017-2022), EVP-Pharmaceuticals, Research & Development at Johnson & Johnson (2022), Vice President at American Society for Microbiology, and Senior Vice President at Merck & Co., Inc. (2016-2017).
Dr. Mammen's education history includes a doctorate degree from Harvard Medical School, an undergraduate degree from Dalhousie University, a doctorate degree from Massachusetts Institute of Technology, and a doctorate degree from Harvard University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
11/06/2024 180 259 ( 0,17% ) 3 M $ 31/10/2024

Postes actifs de Mathai Mammen

SociétésPosteDébut
SANDOZ GROUP AG Directeur/Membre du Conseil 30/04/2024
Directeur Général 01/07/2023
Consultant / Advisor -
Consultant / Advisor 01/01/2019
MIT Jameel Clinic Directeur/Membre du Conseil -
Tous les postes actifs de Mathai Mammen

Anciens postes connus de Mathai Mammen

SociétésPosteFin
10X GENOMICS, INC. Directeur/Membre du Conseil 24/10/2024
JOHNSON & JOHNSON Directeur Technique/Scientifique/R&D 08/08/2022
Corporate Officer/Principal 01/01/2022
MERCK & CO., INC. Corporate Officer/Principal 01/07/2017
░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Mathai Mammen

Formation de Mathai Mammen

Massachusetts Institute of Technology Doctorate Degree
Dalhousie University Undergraduate Degree
Harvard Medical School Doctorate Degree
Harvard University Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Mathai Mammen

Sociétés liées

Sociétés cotées6
INNOVIVA, INC.

Health Technology

THERAVANCE BIOPHARMA, INC.

Health Technology

10X GENOMICS, INC.

Health Technology

JOHNSON & JOHNSON

Health Technology

MERCK & CO., INC.

Health Technology

SANDOZ GROUP AG

Health Technology

Entreprise privées7

Commercial Services

Health Technology

Commercial Services

MIT Jameel Clinic

Finance

Finance

Health Technology

  1. Bourse
  2. Insiders
  3. Mathai Mammen
Prolongation exceptionnelle | BLACK FRIDAY -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT